Compare HAS & BME Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | HAS | BME |
|---|---|---|
| Founded | 1923 | N/A |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Recreational Games/Products/Toys | Trusts Except Educational Religious and Charitable |
| Sector | Consumer Discretionary | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 11.1B | 547.5M |
| IPO Year | 1994 | 2005 |
| Metric | HAS | BME |
|---|---|---|
| Price | $90.97 | $39.17 |
| Analyst Decision | Strong Buy | |
| Analyst Count | 10 | 0 |
| Target Price | ★ $107.30 | N/A |
| AVG Volume (30 Days) | ★ 1.3M | 34.3K |
| Earning Date | 04-23-2026 | 01-01-0001 |
| Dividend Yield | ★ 3.06% | N/A |
| EPS Growth | N/A | ★ N/A |
| EPS | N/A | ★ N/A |
| Revenue | ★ $5,365,900,000.00 | N/A |
| Revenue This Year | $5.33 | N/A |
| Revenue Next Year | $6.99 | N/A |
| P/E Ratio | ★ N/A | N/A |
| Revenue Growth | ★ 13.06 | N/A |
| 52 Week Low | $49.00 | $34.18 |
| 52 Week High | $106.98 | $42.74 |
| Indicator | HAS | BME |
|---|---|---|
| Relative Strength Index (RSI) | 36.03 | 23.09 |
| Support Level | $87.90 | $37.91 |
| Resistance Level | $98.07 | $42.55 |
| Average True Range (ATR) | 2.24 | 0.55 |
| MACD | -0.87 | -0.24 |
| Stochastic Oscillator | 4.84 | 5.56 |
Hasbro is a branded play company providing children and families around the world with entertainment offerings based on a world-class brand portfolio. From toys and games to television programming, motion pictures, and a licensing program, Hasbro reaches customers by leveraging its well-known brands such as Transformers, Nerf, and Magic: The Gathering. The firm acquired EOne in 2019, bolting on popular family properties like Peppa Pig and PJ Masks, and since has divested noncore lines from the tie-up. Furthermore, the addition of Dungeons & Dragons Beyond in 2022, offers the firm access to 19 million digital tabletop players.
Blackrock Health Sciences Trust has an investment objective to provide total return through a combination of current income, current gains, and long-term capital appreciation. The Fund invests 80% of its total assets in equity securities of companies engaged in the health sciences and related industries and equity derivatives.